Filippo Venturini

511 total citations
25 papers, 341 citations indexed

About

Filippo Venturini is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine. According to data from OpenAlex, Filippo Venturini has authored 25 papers receiving a total of 341 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Oncology, 11 papers in Pulmonary and Respiratory Medicine and 6 papers in Pathology and Forensic Medicine. Recurrent topics in Filippo Venturini's work include Colorectal Cancer Treatments and Studies (7 papers), Lung Cancer Treatments and Mutations (7 papers) and Cancer Treatment and Pharmacology (5 papers). Filippo Venturini is often cited by papers focused on Colorectal Cancer Treatments and Studies (7 papers), Lung Cancer Treatments and Mutations (7 papers) and Cancer Treatment and Pharmacology (5 papers). Filippo Venturini collaborates with scholars based in Italy, Germany and Spain. Filippo Venturini's co-authors include Enrico Derenzini, Pier Luigi Zinzani, Michele Baccarani, Vittorio Stefoni, Cinzia Pellegrini, Alessandro Broccoli, L Gandolfi, Federica Quirini, Lisa Argnani and Mariapaola Fina and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer.

In The Last Decade

Filippo Venturini

24 papers receiving 336 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Filippo Venturini Italy 9 198 182 93 76 71 25 341
Kong‐Chao Chang Taiwan 8 111 0.6× 155 0.9× 63 0.7× 28 0.4× 29 0.4× 10 319
Zach Liu United States 10 263 1.3× 225 1.2× 64 0.7× 49 0.6× 125 1.8× 12 445
Narittee Sukswai Thailand 8 120 0.6× 124 0.7× 48 0.5× 63 0.8× 14 0.2× 21 282
Alexandre Rouquette France 9 115 0.6× 204 1.1× 96 1.0× 13 0.2× 111 1.6× 28 416
Limei Poon Singapore 8 332 1.7× 367 2.0× 260 2.8× 46 0.6× 18 0.3× 23 552
Sonia González de Villambrosía Spain 10 345 1.7× 307 1.7× 63 0.7× 51 0.7× 19 0.3× 25 444
Federica Quirini Italy 11 372 1.9× 179 1.0× 115 1.2× 87 1.1× 52 0.7× 17 432
Ken Ohmachi Japan 13 403 2.0× 342 1.9× 91 1.0× 42 0.6× 46 0.6× 46 599
Ilaria Marcon Italy 7 75 0.4× 290 1.6× 50 0.5× 50 0.7× 109 1.5× 17 366

Countries citing papers authored by Filippo Venturini

Since Specialization
Citations

This map shows the geographic impact of Filippo Venturini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Filippo Venturini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Filippo Venturini more than expected).

Fields of papers citing papers by Filippo Venturini

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Filippo Venturini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Filippo Venturini. The network helps show where Filippo Venturini may publish in the future.

Co-authorship network of co-authors of Filippo Venturini

This figure shows the co-authorship network connecting the top 25 collaborators of Filippo Venturini. A scholar is included among the top collaborators of Filippo Venturini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Filippo Venturini. Filippo Venturini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fuereder, Thorsten, Ye Guo, Lisa Licitra, et al.. (2025). Treatment decision-making factors and sequencing in recurrent and/or metastatic squamous cell carcinoma of the head and neck. Cancer Treatment Reviews. 135. 102910–102910. 1 indexed citations
2.
Venturini, Filippo, et al.. (2025). Scaling Swarm Coordination with GNNs—How Far Can We Go?. AI. 6(11). 282–282.
3.
Malapelle, Umberto, Natasha B. Leighl, Alfredo Addeo, et al.. (2024). Recommendations for reporting tissue and circulating tumour (ct)DNA next-generation sequencing results in non-small cell lung cancer. British Journal of Cancer. 131(2). 212–219. 12 indexed citations
4.
Antonuzzo, Lorenzo, Rosa Tambaro, Sebastiano Buti, et al.. (2024). READY: REAl-world Data from an Italian compassionate use program of avelumab first-line maintenance for locallY advanced or metastatic urothelial carcinoma. SHILAP Revista de lepidopterología. 5. 100068–100068. 4 indexed citations
5.
Bracarda, Sergio, Lorenzo Antonuzzo, Marco Maruzzo, et al.. (2024). Subgroup analyses from READY: Real-world data from an Italian compassionate use program (CUP) of avelumab first-line maintenance (1LM) treatment for locally advanced or metastatic urothelial carcinoma (la/mUC).. Journal of Clinical Oncology. 42(4_suppl). 558–558. 5 indexed citations
6.
Cremolini, Chiara, Clara Montagut, Philippe Ronga, et al.. (2023). Rechallenge with anti-EGFR therapy to extend the continuum of care in patients with metastatic colorectal cancer. Frontiers in Oncology. 12. 946850–946850. 13 indexed citations
8.
Grignani, Giovanni, Vanna Chiarion‐Sileni, Carmine Pinto, et al.. (2021). Avelumab treatment in Italian patients with metastatic Merkel cell carcinoma: experience from an expanded access program. Journal of Translational Medicine. 19(1). 70–70. 4 indexed citations
9.
Venturini, Filippo, Stefano Di Lernia, Angelo Vanzulli, et al.. (2014). Linitis Plastica of the Rectum As a Clinical Presentation of Metastatic Lobular Carcinoma of the Breast. Journal of Clinical Oncology. 34(7). e54–e56. 8 indexed citations
10.
Pietrantonio, Filippo, Federica Perrone, Pamela Biondani, et al.. (2013). Single agent panitumumab in KRAS wild-type metastatic colorectal cancer patients following cetuximab-based regimens. Cancer Biology & Therapy. 14(12). 1098–1103. 24 indexed citations
13.
Ricotta, Riccardo, Angelo Vanzulli, Mauro Moroni, et al.. (2012). Magnetic Resonance Imaging as an Early Indicator of Clinical Outcome in Patients With Metastatic Colorectal Carcinoma Treated With Cetuximab or Panitumumab. Clinical Colorectal Cancer. 12(1). 45–53. 12 indexed citations
14.
Venturini, Filippo, et al.. (2011). Cardiotoxicity of novel molecular targeted therapies of cancer. Journal of Cardiovascular Echography. 21(2). 78–85. 1 indexed citations
15.
Sartore‐Bianchi, Andrea, Katia Bencardino, Andrea Cassingena, et al.. (2010). Therapeutic implications of resistance to molecular therapies in metastatic colorectal cancer. Cancer Treatment Reviews. 36. S1–S5. 24 indexed citations
16.
Zinzani, Pier Luigi, Filippo Venturini, Vittorio Stefoni, et al.. (2009). Gemcitabine as single agent in pretreated T-cell lymphoma patients: evaluation of the long-term outcome. Annals of Oncology. 21(4). 860–863. 126 indexed citations
17.
Derenzini, Enrico, Cinzia Pellegrini, Filippo Venturini, et al.. (2009). MACOP-B regimen in the treatment of adult Langerhans cell histiocytosis: experience on seven patients. Annals of Oncology. 21(6). 1173–1178. 33 indexed citations
19.
Derenzini, Enrico, Gerardo Musuraca, Stefano Fanti, et al.. (2008). Pretransplantation positron emission tomography scan is the main predictor of autologous stem cell transplantation outcome in aggressive B‐cell non‐Hodgkin lymphoma. Cancer. 113(9). 2496–2503. 49 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026